What does Apotheek Sigrid Saelens do?

Apotheek Sigrid Saelens is a pharmacy in Poperinge. Private Limited, started on 21 April 2010, 1 establishment.

What is the address of Apotheek Sigrid Saelens?

The registered office of Apotheek Sigrid Saelens is located at Paardenmarkt 7, 8970 Poperinge.

Is Apotheek Sigrid Saelens still active?

Yes. According to the CBE (30 October 2026) Apotheek Sigrid Saelens is active, legal situation “Normale toestand”, started on 21 April 2010.

Is Apotheek Sigrid Saelens registered on Peppol?

Yes, Apotheek Sigrid Saelens is registered on the Peppol network with ID 0208:0825222352.

What is the enterprise number of Apotheek Sigrid Saelens?

The enterprise number of Apotheek Sigrid Saelens is BE0825222352.

When was Apotheek Sigrid Saelens founded?

Apotheek Sigrid Saelens was founded on 21 April 2010.

Who are the directors of Apotheek Sigrid Saelens?

According to the 2025 annual accounts, the directors of Apotheek Sigrid Saelens are: Saelens pharma.

Is Apotheek Sigrid Saelens a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 April 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Sigrid Saelens make in 2025?

Apotheek Sigrid Saelens posted a profit after taxes of € 65,975 in financial year 2025.

What is the revenue of Apotheek Sigrid Saelens?

As a small company, Apotheek Sigrid Saelens is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 138,640.

How much does an employee at Apotheek Sigrid Saelens earn?

The average wage cost per full-time employee at Apotheek Sigrid Saelens was € 56,500 in 2024: staff costs of € 62,167 for 1.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Sigrid Saelens have?

According to the 2025 annual accounts, Apotheek Sigrid Saelens has 0.7 full-time equivalents (FTE).

Apotheek Sigrid Saelens (Private Limited) - Poperinge

Dossier Apotheek Sigrid Saelens, printed on 30 October 2026 from databakkes.be/en/0825222352/apotheek-sigrid-saelens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Sigrid Saelens from Poperinge, company number BE0825222352, closed financial year 2025 with a result of € 65,975 after tax. For that financial year Apotheek Sigrid Saelens recorded a gross margin of € 138,640 and equity of € 827,317. Compared with financial year 2024, the result moved from € 88,956 to € 65,975. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Healthy

€ 827,317

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 65,975

▼ 26% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 654,770

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0.7

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 30,689

▼ 51% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 769

▼ 59% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 61,711

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,110

▲ € 5,072 vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2023	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 156,423 Gross margin 2023: € 156,423 First fiscal year in the series	€ 127,893 Gross margin 2023: € 127,893 ▼ 18% vs 2023 (€ 156,423) Unfavourable step	€ 200,273 Gross margin 2024: € 200,273 ▲ 57% vs 2023 (€ 127,893) Favourable step	€ 138,640 Gross margin 2025: € 138,640 ▼ 31% vs 2024 (€ 200,273) Unfavourable step	▼ 31%
Profit after taxes	€ 79,653 Profit after taxes 2023: € 79,653 First fiscal year in the series	€ 67,080 Profit after taxes 2023: € 67,080 ▼ 16% vs 2023 (€ 79,653) Unfavourable step	€ 88,956 Profit after taxes 2024: € 88,956 ▲ 33% vs 2023 (€ 67,080) Favourable step	€ 65,975 Profit after taxes 2025: € 65,975 ▼ 26% vs 2024 (€ 88,956) Unfavourable step	▼ 26%
Equity	€ 692,906 Equity 2023: € 692,906 First fiscal year in the series	€ 772,386 Equity 2023: € 772,386 ▲ 11% vs 2023 (€ 692,906) Favourable step	€ 861,342 Equity 2024: € 861,342 ▲ 12% vs 2023 (€ 772,386) Favourable step	€ 827,317 Equity 2025: € 827,317 ▼ 4% vs 2024 (€ 861,342) Unfavourable step	▼ 4%
Total debts	€ 228,127 Total debts 2023: € 228,127 First fiscal year in the series	€ 161,971 Total debts 2023: € 161,971 ▼ 29% vs 2023 (€ 228,127) Favourable step	€ 144,484 Total debts 2024: € 144,484 ▼ 11% vs 2023 (€ 161,971) Favourable step	€ 244,284 Total debts 2025: € 244,284 ▲ 69% vs 2024 (€ 144,484) Unfavourable step	▲ 69%
Cash	€ 582,765 Cash 2023: € 582,765 First fiscal year in the series	€ 499,341 Cash 2023: € 499,341 ▼ 14% vs 2023 (€ 582,765) Unfavourable step	€ 555,719 Cash 2024: € 555,719 ▲ 11% vs 2023 (€ 499,341) Favourable step	€ 654,770 Cash 2025: € 654,770 ▲ 18% vs 2024 (€ 555,719) Favourable step	▲ 18%
Retained profit	€ 686,706 Retained profit 2023: € 686,706 First fiscal year in the series	€ 753,786 Retained profit 2023: € 753,786 ▲ 10% vs 2023 (€ 686,706) Favourable step	€ 842,742 Retained profit 2024: € 842,742 ▲ 12% vs 2023 (€ 753,786) Favourable step	€ 808,717 Retained profit 2025: € 808,717 ▼ 4% vs 2024 (€ 842,742) Unfavourable step	▼ 4%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2025: € 100,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 921,033 Balance sheet total 2023: € 921,033 First fiscal year in the series	€ 934,356 Balance sheet total 2023: € 934,356 ▲ 1% vs 2023 (€ 921,033) Unchanged	€ 1,005,826 Balance sheet total 2024: € 1,005,826 ▲ 8% vs 2023 (€ 934,356) Unchanged	€ 1,071,601 Balance sheet total 2025: € 1,071,601 ▲ 7% vs 2024 (€ 1,005,826) Unchanged	▲ 7%
Employees (FTE)	0.4 Employees (FTE) 2023: 0.4 First fiscal year in the series	0.6 Employees (FTE) 2023: 0.6 ▲ 0.2 vs 2023 (0.4) Unchanged	1.1 Employees (FTE) 2024: 1.1 ▲ 0.5 vs 2023 (0.6) Unchanged	0.7 Employees (FTE) 2025: 0.7 ▼ 0.4 vs 2024 (1.1) Unchanged	▼ 0.4

Key figures of Apotheek Sigrid Saelens, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Sigrid Saelens?

What happened at Apotheek Sigrid Saelens in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 65,975 (▼ 26% vs 2024). Source: NBB ↗
May 12, 2010 New establishment in Poperinge. KBO
Apr 21, 2010 Start of the company according to the CBE. KBO

In short

From € 79,653 profit in 2023 to € 65,975 profit in 2025.

Paid € 102,314 in corporate taxes since 2023.

Best year ever: 2024, with € 88,956 profit.

On average € 182,100 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

SAELENS PHARMA 99%

The stake of SAELENS PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Sigrid Saelens

Behind Apotheek Sigrid Saelens is Saelens pharma. The shares are held by SAELENS PHARMA (99%).

Directors

According to the 2025 annual accounts

Saelens pharma

Director

Shareholders

SAELENS PHARMA

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Paardenmarkt 7

8970 Poperinge

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SAELENS PHARMA same network

€ 178,191 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0825.222.352
VAT number: BE 0825.222.352
Registered office: Paardenmarkt 7, 8970 Poperinge
Names & denominations: Apotheek Sigrid Saelens
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 April 2010
Peppol: Active · Active since 16 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗